what is the degree of this burn?
what is the management?
what is the prognosis?
N.B dont forget to answer the question, upper right screen
Wednesday, January 25, 2012
Saturday, January 21, 2012
Evaluation and Management of Abnormal Uterine Bleeding in Premenopausal Women
harmacologic Treatment of Abnormal Uterine Bleeding
Medication | Dosage | Cost of generic (brand)[*] | Comments |
---|---|---|---|
Anovulatory bleeding | |||
Combination oral contraceptives[4] | ≤ 35 mcg of ethinyl estradiol monophasic or triphasic pills | NA ($9 to 92) |
Contraindications include smokers older than 35 years, personal history or high risk of deep venous thrombosis or pulmonary embolism, multiple risk factors for arterial cardiovascular disease, history of breast cancer, and severe cirrhosis or liver cancer[33] |
Medroxyprogesterone acetate (Provera)[9] | 10 mg per day for 10 to 14 days per month | $13 ($38) | |
Endometrial hyperplasia without atypia | |||
Medroxyprogesterone acetate[14] | 10 mg per day for 14 days per month | $13 ($38) | |
Megestrol (Megace)[11] | 40 mg per day | $25 (NA as tablets) | |
Levonorgestrel-releasing intrauterine system (Mirena)[31] | Releases 20 mcg per 24 hours | NA ($562[‡]) |
Provides contraception for five years May cause irregular bleeding or amenorrhea Contraindications include breast cancer; uterine anomaly that distorts the cavity; acute pelvic or cervical infection; and severe cirrhosis or liver cancer[33] More expensive initially, but similar to other therapies when averaged over five years |
Ovulatory bleeding | |||
Levonorgestrel-releasing intrauterine system [34] , [35] | Releases 20 mcg per 24 hours | NA ($562[‡]) | FDA-approved for menorrhagia in 2009; see additional comments above |
Medroxyprogesterone acetate[34] | 10 mg per day for 21 days per month | $16 ($40) | |
NSAIDs [36] , [37] | |||
Ibuprofen | 600 to 1,200 mg per day, five days per month | $4 ($16) | |
Naproxen sodium (Anaprox) | 550 to 1,100 mg per day, five days per month | $4 ($50) | Caution in patients with gastrointestinal risks |
Mefenamic acid (Ponstel) | 1,500 mg per day, five days per month | $429 ($553) | |
Tranexamic acid (Lysteda) [38] , [39] | 650 mg; two tablets three times per day, five days per month | NA ($170) |
Begin first day of menses and continue for five days [38] , [39] Caution in patients with history or risk of thromboembolic or renal disease Contraindicated if patient has active intravascular clotting or subarachnoid hemorrhage Considerably more expensive than other available therapies |
Saturday, January 14, 2012
Osteoarthritis: Diagnosis and Treatment
Osteoarthritis is a common degenerative disorder of the articular cartilage associated with hypertrophie bone changes. Risk factors include genetics, female sex, past trauma, advancing age, and obesity. The diagnosis is based on a history of joint pain worsened by movement, which can lead to disability in activities of daily living. Plain radiography may help in the diagnosis, but laboratory testing usually does not. Pharmacologic treatment should begin with acetaminophen and step up to nonsteroidal anti-inflammatory drugs. Exercise is a useful adjunct to treatment and has been shown to reduce pain and disability. The supplements glucosamine and chondroitin can be used for moderate to severe osteoarthritis when taken in combination. Corticosteroid injections provide inexpensive, short-term (four to eight weeks) relief of osteoarthritic flare-ups of the knee, whereas hyaluronic acid injections are more expensive but can maintain symptom improvement for longer periods. Total joint replacement of the hip, knee, or shoulder is recommended for patients with chronic pain and disability despite maximal medical therapy
- Signs and Symptoms of Osteoarthritis
Pain on range of motion Hypertrophic changes at distal and proximal interphalangeal joints (Heberden nodes and Bouchard nodes; Figure 1) Tenderness over metacarpophalangeal joint of thumb |
SORT: KEY RECOMMENDATIONS FOR PRACTICE
Clinical recommendation | Evidence rating | References |
---|---|---|
Physical therapy using land-based or water-based exercise can help reduce pain and improve function in patients with osteoarthritis | B | [10] , [11] ,[12] |
Acetaminophen should be used as first-line therapy for mild osteoarthritis. | A | 16 |
Nonsteroidal anti-inflammatory drugs are superior to acetaminophen for treating moderate to severe osteoarthritis | A | 16 |
Intra-articular corticosteroid injections can be beneficial for short-term (i.e., less than eight weeks) relief of osteoarthritis pain of the knee. | A | [21] , [22] |
Compared with intra-articular corticosteroids, intra-articular hyaluronic acid njections of the knee are less effective in the short term, equivalent in the ntermediate term (i.e., four to eight weeks), and superior in the long term | B | [26] , [27] |
The combination of glucosamine and chondroitin may decrease pain in patients with moderate to severe knee osteoarthritis, although the evidence for this effect is limited and inconsistent. | B | 30 |
Patients who have continued pain and disability from osteoarthritis of the hip, knee, or shoulder despite maximal medical therapy are candidates for total joint replacement. |
Complementary and Alternative Medicine
A meta-analysis on the effectiveness of acupuncture for osteoarthritis of the knee found only short-term benefit, which the authors described as clinically irrelevant.[28] Acupuncture can be of benefit in chronic low back pain, but studies do not differentiate the etiology of the back pain.[29]
The most widely used supplements for osteoarthritis are glucosamine and chondroitin. The literature consisted of small clinical trials until the release of the Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT), which included more than 1,500 patients. The trial had five arms comparing glucosamine alone, chondroitin alone, a combination of glucosamine and chondroitin, celecoxib, and placebo. The results were favorable only for the combination of glucosamine and chondroitin, which appeared to be effective for moderate to severe osteoarthritis of the knee.[30] Chondroitin alone did not show benefit for osteoarthritis of the knee or hip in a meta-analysis.[31]
Balneotherapy is a heterogeneous group of treatments also known as spa therapy or mineral baths. A Cochrane review concluded that mineral baths were of some benefit to patients with osteoarthritis, but the authors addressed methodologic flaws in the studies and urged caution in interpreting the findings.[32] Capsaicin cream is a topical analgesic derived from chili peppers. It has been found to be superior to placebo in treating osteoarthritis pain. It is widely available, is relatively inexpensive, and can be used as an adjunct to standard osteoarthritis treatments.[33] There also is evidence supporting the use of the supplement S-adenosylmethionine (SAM-e) to reduce functional limitation, but not compared with placebo in patients with osteoarthritis pain. The effectiveness of SAM-e is comparable to that of NSAIDs in some studies but with fewer adverse effects.[34]
Surgical
Surgery should be reserved for patients whose symptoms have not responded to other treatments. The well-accepted indication for surgery is continued pain and disability despite conservative treatment. The most effective surgical intervention is total joint replacement, with excellent patient outcomes following total joint replacement of the hip, knee, and shoulder. [1] , [35] Many different prosthetic devices are available; however, controlled trials comparing the various devices are lacking. Patients can expect that most current joint prostheses will function well for 15 to 20 years.[35]
There are other surgical approaches to osteoarthritis treatment, but they have not equaled the success of total joint replacement. Randomized trials of arthroscopic debridement for osteoarthritis of the knee have consistently failed to show an advantage over maximal medical therapy combined with physical therapy.[36]
Thursday, January 5, 2012
IBS
Diagnostic Criteria for IBS
Signs and Symptoms Suggesting Alternative Diagnosis to Irritable Bowel Syndrome
Medications for Treatment of Irritable Bowel Syndrome
Abdominal discomfort or pain, for at least 12 weeks (which need not be consecutive) in the preceding 12 months, with two of the following features: | |
Relief with defecation | |
Onset associated with a change in stool frequency | |
Onset associated with a change in form or appearance of stool | |
These additional symptoms cumulatively support the diagnosis of IBS: | |
Abnormal stool frequency (more than three times per day or less than three times per week) | |
Abnormal stool form (loose and watery or lumpy and hard) | |
Abnormal stool passage (urgency, frequency, feeling of incomplete evacuation) | |
Passage of mucus (white material) | |
Bloating or sensation of abdominal distention |
Sign or symptoms | Suggested diagnosis |
---|---|
Alarm factors | |
Anemia | Cancer, IBD |
Chronic severe diarrhea | Cancer, infection, IBD |
Family history of colon cancer | Cancer |
Hematochezia, melena, or other signs of intestinal bleeding | Cancer, arteriovenous malformation, colonic polyps, IBD |
Recurrent fever | Infection, IBD |
Weight loss | Cancer, IBD |
Other signs and symptoms | |
Travel to areas with parasitic diseases | Infection |
Family history of colon cancer, irritable bowel syndrome, celiac disease | Cancer, celiac disease |
Signs or symptoms of malabsorption | Celiac disease |
Nighttime symptoms (e.g., encopresis) | Infection, trauma |
Onset after 50 years of age | Cancer |
Arthritis | Arthritis |
Thyroid dysfunction |
Treatment | Initial dosage | Maintenance dosage | Cost (generic)* | Comments |
---|---|---|---|---|
Dicyclomine (Bentyl) | 20 mg fourtimes per day | 20 to 40 mg four times per day | $63 (22 to 82) | If not effective in two weeks, discontinue. |
Hyoscyamine (Levsin) | 0.125 to 0.250 mg every four hours | Same | 145 (52 to 61) | Anticholinergic effects; maximum 1.5 gm per day |
Loperamide (Imodium) | 4 mg | 4 to 8 mg per day | 49 (15 to 42) | — |
Amitriptyline | 10 to 25 mg every night at bedtime | 10 to 100 mg every night at bedtime | 8 (2 to 10) | Large dosing range; start low, and titrate as needed. |
Desipramine (Norpramin) | 10 to 50 mg every night at bedtime | 10 to 150 mg every night at bedtime | 21 (12 to 21) | Large dosing range; start low, and titrate as needed. |
Alosetron (Lotronex) | 1 mg per day for four weeks | 1 mg once or twice per day | 216 | Use in women with diarrheapredominant irritable bowel syndrome; use with caution; available only through prescribing program; associated with ischemic colitis. |
Tegaserod (Zelnorm) | 6 mg twice per day for four to 12 weeks | Same | 169 | Use in constipation with same caveats as alosetron; only indicated for 12 weeks of therapy. |
Subscribe to:
Posts (Atom)